Lihat sumber Vaksin HIV

'''Vaksin HIV''' adalah [[vaksin]] hipotesis [[HIV]], penyebab [[AIDS]]. Karena AIDS belum ada obatnya, pencarian vaksin merupakan bagian dari perlawanan terhadap penyakit ini.

Keadaan mendesak untuk penelitian vaksin [[HIV]] merupakan akibat dari kematian lebih dari 25 juta orang sejak tahun [[1981]] akibat dari AIDS. Pada tahun [[2002]], [[AIDS]] menjadi akibat utama [[mortalitas]] karena infeksi di [[Afrika]]. Penelitian terus dilakukan, tetapi, setelah 20 tahun penelitian, HIV-1 tetap merupakan target vaksin yang sulit.

Terdapat perawatan lain selain vaksin HIV, seperti [[terapi antiretroviral]].

== Rujukan ==
=== Referensi ===

* Berman, P. W., Gregory, T. J., Riddle, L., Nakamura, G. R., Champe, M. A., Porter, J. P., Wurm, F. M., Hershberg, R. D., Cobb, E. K. and Eichberg, J. W. (1990) Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. ''Nature'' '''345''', 622-625
* Connor, R. I., Korber, B. T., Graham, B. S., Hahn, B. H., Ho, D. D., Walker, B. D., Neumann, A. U., Vermund, S. H., Mestecky, J., Jackson, S., Fenamore, E., Cao, Y., Gao, F., Kalams, S., Kunstman, K. J., McDonald, D., McWilliams, N., Trkola, A., Moore, J. P. and Wolinsky, S. M. (1998) Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines. ''J. Virol.'' '''72''', 1552-1576
* McCutchan, F. E. (2000b) Understanding the genetic diversity of HIV-1. ''AIDS'' '''14''', S31-S44
* Peeters, M. and Sharp, P. M. (2000) Genetic diversity of HIV-1: the moving target. ''AIDS'' '''14''', S129-S140
* Poignard, P., Sabbe, R., Picchio, G. R., Wang, M., Gulizia, R. J., Katinger, H., Parren, P. W., Mosier, D. E. and Burton, D. R. (1999) Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo. ''Immunity'' '''10''', 431-438
* Romano, L., Venturi, G., Giomi, S., Pippi, L., Valensin, P. E. and Zazzi, M. (2002) Development and significance of resistance to protease inhibitors in HIV-1 infected adults under triple-drug therapy in clinical practice. ''J. Med. Virol.' '''66''', 143-150
* Specter, Michael. Political Science: The Bush Administration's war on the laboratory. The New Yorker. [[March 13]] [[2006]].
* UNAIDS (2004) Report on the global AIDS epidemic, July 2004


=== Catatan ===


== Pranala luar ==

* [http://www.vrc.nih.gov Vaccine Research Center (VRC)] - Informasi mengenai riset vaksin HIV
* [http://www.niaid.nih.gov/daids/vaccine/default.htm NIAID HIV vaccine site] ([[Division of Acquired Immunodeficiency Syndrome|DAIDS]])
* [http://www.vaccinealliance.org Global Alliance for Vaccines and Immunization (GAVI)]
* [http://www.iavi.org International AIDS Vaccine Initiative (IAVI)]
* [http://www.avac.org AIDS Vaccine Advocacy Coalition (AVAC)]
* [http://www.aidsvaccine.org Capital Area Vaccine Effort (CAVE]
* [http://briandeer.com/vaxgen-aidsvax.htm Investigation of first candidate vaccine]
* [http://blogs.cgdev.org/vaccine Vaccines for Development]
* [http://www.bethegeneration.org Be the Generation - Information on HIV Vaccine Clinical Research in 20 American Cities]
* [http://www.holdsworthhouse.com.au/clinical_about_research.php Australian recruiter for HIV treatment studies]
* [http://ec.europa.eu/research/health/poverty-diseases/projects/84_en.htm Aids Vaccine Integrated Project] ''([[European Union]] research programme)''
* [http://www.aids.gov AIDS.gov - The U.S. Federal Domestic HIV/AIDS Resource]
* [http://www.HIVtest.org HIVtest.org - Menemukan lokasi tes HIV]
* [http://seattletimes.nwsource.com/html/health/2003973431_aids25.html Vaksin HIV dapat meningkatkan risiko penularan]



== Sumber dan atribusi ==

Konten artikel ini diadaptasi dari [https://id.wikipedia.org/w/index.php?title=Vaksin+HIV&oldid=28579952 Wikipedia bahasa Indonesia], revisi 28579952 (2025-11-21T03:30:08Z), yang tersedia berdasarkan lisensi Creative Commons Atribusi-BerbagiSerupa (CC BY-SA). Mohon gunakan konten ini secara bijak serta sesuai dengan ketentuan lisensi yang berlaku.